ArticleLaboratory medicine2026
Vitamin D receptor gene variations and their association with cardiometabolic risk and microvascular complications in metabolic dysfunction-associated steatotic liver disease: evidence from a Turkish cohort.
Article in Laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of the VDR rs1544410 Polymorphism with Metabolic Syndrome and Cardiometabolic Traits in Institutionalized Older Adults.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionVitamin D receptor (VDR) variations have attracted attention because of their potential impact on metabolic regulation and liver health. This study aimed to investigate the association between VDR polymorphisms and clinical parameters as well as the risk of metabolic dysfunction-associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease) in a Turkish population.
methodsThe study included 390 participants: 200 patients with MASLD and 190 healthy control individuals. VDR rs1544410, rs2228570, and rs731236 variations were genotyped using the polymerase chain reaction-restriction fragment length polymorphism method.
resultsThere was no statistically significant difference in the overall genotype distribution of VDR variants between patients and control individuals. The rs1544410 AA and AG genotypes were associated with higher triglyceride levels. The rs2228570 CT genotype was associated with increased hypertriglyceridemia and hypertension, whereas the CC genotype was more frequent in patients with microvascular complications. The rs731236 CC and CT genotypes were also associated with a higher risk of hypertriglyceridemia. DISCUSSION: Our study revealed that the VDR rs1544410, VDR rs2228570, and VDR rs731236 variations substantially modulate the risk of hypertriglyceridemia, hypertension, and microvascular complications in MASLD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.